Holders — by stockHoldings — by fund
Propel Bio Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001969764
$188.6M
disclosed book value
30
positions
17.5%
largest position share
Positions, as of 2026-09-30
top 30 of 30 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PAGPPLAINS GP HOLDINGS LP | 1.3M | $33.0M | 17.5% |
| 2 | ACHVACHIEVE LIFE SCIENCES INC | 3.9M | $31.3M | 16.6% |
| 3 | DCTHDELCATH SYSTEMS INC | 604,664 | $9.7M | 5.1% |
| 4 | COLLCOLLEGIUM PHARMACEUTICAL | 410,175 | $9.0M | 4.7% |
| 5 | CORTCORCEPT THERAPEUTICS INC | 75,274 | $8.7M | 4.6% |
| 6 | AQSTAQUESTIVE THERAPEUTICS INC | 278,723 | $8.6M | 4.6% |
| 7 | MISTMILESTONE PHARMACEUTICALS | 9.4M | $8.2M | 4.3% |
| 8 | PHATPHATHOM PHARMACEUTICALS I | 1.1M | $8.1M | 4.3% |
| 9 | CMPSCOMPASS PATHWAYS PLC | 549,186 | $6.8M | 3.6% |
| 10 | OBIOORCHESTRA BIOMED HOLDINGS | 896,701 | $5.6M | 3% |
| 11 | MAZEMAZE THERAPEUTICS INC | 191,998 | $5.2M | 2.8% |
| 12 | ABEOABEONA THERAPEUTICS INC | 956,007 | $5.0M | 2.7% |
| 13 | ARTVARTIVA BIOTHERAPEUTICS IN | 696,436 | $5.0M | 2.6% |
| 14 | KYTXKYVERNA THERAPEUTICS INC | 700,595 | $4.8M | 2.5% |
| 15 | IVAINVENTIVA SA - ADR | 1.1M | $4.2M | 2.2% |
| 16 | CABACABALETTA BIO INC | 2.0M | $3.9M | 2.1% |
| 17 | SABSSAB BIOTHERAPEUTICS INC | 1.2M | $3.8M | 2% |
| 18 | PROKPROKIDNEY CORP | 2.0M | $3.3M | 1.8% |
| 19 | CRVSCORVUS PHARMACEUTICALS INC | 264,310 | $3.0M | 1.6% |
| 20 | PALIPALISADE BIO INC | 2.2M | $3.0M | 1.6% |
| 21 | OCULOCULAR THERAPEUTIX INC | 357,966 | $2.7M | 1.5% |
| 22 | SCYXSCYNEXIS INC | 541,474 | $2.7M | 1.4% |
| 23 | FDMT4D MOLECULAR THERAPEUTICS IN | 179,154 | $2.6M | 1.4% |
| 24 | OVIDOVID THERAPEUTICS INC | 1.0M | $2.5M | 1.3% |
| 25 | IMUXIMMUNIC INC | 236,734 | $2.2M | 1.2% |
| 26 | UPBUPSTREAM BIO INC | 335,389 | $1.8M | 0.9% |
| 27 | IRDOPUS GENETICS INC | 270,036 | $1.3M | 0.7% |
| 28 | CLDXCELLDEX THERAPEUTICS INC | 37,539 | $1.2M | 0.6% |
| 29 | SGPSPYGLASS PHARMA INC | 41,418 | $1.1M | 0.6% |
| 30 | LONALEONABIO INC | 149,279 | $532,926 | 0.3% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.